CARDIOVASCULAR RISK
Clinical trials for CARDIOVASCULAR RISK explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR RISK trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could stop second heart attacks
Disease control Recruiting nowThis study tests a new medicine called ziltivekimab in 10,000 adults who recently had a heart attack. Participants inject the drug or a placebo into their belly, thigh, or arm once a month for about 2 years. The goal is to see if ziltivekimab reduces the risk of another heart att…
Matched conditions: CARDIOVASCULAR RISK
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 04:13 UTC
-
App attack on cholesterol: digital program aims to slash heart risk in 1,000 patients
Disease control Recruiting nowThis study tests a digital health program called Corrie Lipids in about 1,000 adults with high LDL cholesterol and elevated heart disease risk. Participants use a smartphone app, get clinician coaching, and have their care streamlined to help them reach cholesterol goals. The goa…
Matched conditions: CARDIOVASCULAR RISK
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
New study reveals hidden diabetes risks in cystic fibrosis patients
Knowledge-focused Recruiting nowThis study will enroll 200 adolescents and adults with cystic fibrosis-related diabetes (CFRD) to find out how common complications like eye, kidney, and nerve problems are. Researchers will also check blood pressure and cholesterol. The goal is to better understand these risks a…
Matched conditions: CARDIOVASCULAR RISK
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated May 26, 2026 04:13 UTC
-
30,000 italians join study to revolutionize heart risk prediction
Knowledge-focused Recruiting nowThis study is testing whether adding genetic and imaging information to standard risk tools can better predict heart disease in 30,000 healthy Italian adults aged 40-80. Participants are grouped by current risk level and followed for one year to see if the extra data leads to imp…
Matched conditions: CARDIOVASCULAR RISK
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC